Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005352886 | SCV006024826 | uncertain significance | Inborn genetic diseases | 2025-01-21 | criteria provided, single submitter | clinical testing | The c.2320G>A (p.A774T) alteration is located in exon 14 (coding exon 14) of the KMT2C gene. This alteration results from a G to A substitution at nucleotide position 2320, causing the alanine (A) at amino acid position 774 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |